Press-release for stocks publishing date 2021 - 08 - 02 in the health technology sector

publishing date : 2021 - 08 - 02 sector : Health technology

save search

Cassava Sciences Announces Conference Call for Second Quarter Financial Results
Published: 2021-08-02 (Crawled : 00:00) - globenewswire.com
SAVA | $19.61 -7.46% -8.06% 1.3M

Health Technology

| -73.41% | O: 8.46% H: 7.93% C: -2.18%
financial results results conference

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-08-02 (Crawled : 22:00) - globenewswire.com
CYTK | $67.49 0.73% 0.73% 1.5M

Health Technology

| 139.83% | O: 0.21% H: 1.35% C: 0.0%
granted grant nasdaq

Arch Oncology Strengthens Medical and Clinical Leadership Teams with Key Appointments
Published: 2021-08-02 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -15.94% | O: 0.02% H: 0.21% C: -0.12%

Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021
Published: 2021-08-02 (Crawled : 22:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M

Health Technology

| 34.48% | O: -0.44% H: 0.89% C: 0.88%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 206.82% | O: 0.43% H: 0.88% C: 0.35%
ALNY | $144.315 -0.58% -0.59% 700K

Health Technology

| -20.06% | O: -1.81% H: 0.94% C: -0.19%
financial results results

SCYNEXIS Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-08-02 (Crawled : 22:00) - globenewswire.com
SCYX | $1.44 2.49% 2.43% 130K

Health Technology

| -79.33% | O: 0.0% H: 0.58% C: 0.58%
granted grant nasdaq

CMS Grants Additional Reimbursement For EXALT™ Model D Single-Use Duodenoscope
Published: 2021-08-02 (Crawled : 21:00) - prnewswire.com
BSX | $67.33 -0.13% -0.31% 7M

Health Technology

| 46.95% | O: 0.04% H: 0.05% C: -0.78%
granted grant

Data Release: Human Microbiome Samples Demonstrate Advances in HiFi-Enabled Metagenomic Sequencing
Published: 2021-08-02 (Crawled : 21:00) - pacb.com
PACB | $1.55 6.16% 5.81% 17M

Health Technology

| -95.52% | O: 0.96% H: 0.55% C: -4.22%
genomic

GSK files for licensure of MMR vaccine in the US
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| -1.17% | O: -0.37% H: 0.98% C: 0.8%
vaccine

Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
GOSS 4 | $0.7837 -2.77% -2.85% 670K

Health Technology

| -89.57% | O: 0.13% H: 1.65% C: -2.54%
financial results results conference

Mereo BioPharma to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
RARE | News F | $42.37 -2.33% -2.38% 680K

Health Technology

| -44.75% | O: 0.16% H: 2.6% C: 1.1%
MREO | $2.64 -0.38% -0.38% 910K

Health Technology

| 0.39% | O: 0.0% H: 4.47% C: 2.72%
biopharma biotech technology iot conference

INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama
Published: 2021-08-02 (Crawled : 21:00) - invobioscience.com
INVO | $1.345 -11.51% -13.01% 1.4M

Health Technology

| -82.73% | O: -0.23% H: 0.46% C: 0.46%
bioscience

Inventiva announces the implementation of an At-The-Market program in the United States
Published: 2021-08-02 (Crawled : 21:00) - inventivapharma.com
IVA | $3.35 -2.9% -2.99% 8.5K

Health Technology

| -76.15% | O: -3.33% H: 1.0% C: 0.54%

Precigen to Announce Second Quarter and First Half 2021 Financial Results on August 9th
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
PGEN | $1.33 0.76% 0.75% 1M

Health Technology

| -76.14% | O: 0.36% H: 3.54% C: 1.81%
financial results results

REGENXBIO to Host Conference Call on August 9 to Discuss Second Quarter 2021 Financial Results and Recent Operational Highlights
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
RGNX | $15.67 -2.73% -2.87% 570K

Health Technology

| -47.31% | O: 0.34% H: 3.48% C: -1.45%
financial results results conference

Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
Published: 2021-08-02 (Crawled : 21:00) - biospace.com/
PSNL | $1.31 8.26% 7.63% 280K

Health Technology

| -94.28% | O: 0.62% H: 0.71% C: -1.47%
immunotherapy therapy cancer biomarkers

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-08-02 (Crawled : 21:00) - globenewswire.com
OYST | $11.17 0.18% -0.27%

Health Technology

| -20.98% | O: -3.83% H: 4.57% C: 0.88%
granted grant nasdaq pharma

ClearPoint Neuro to Announce Second Quarter 2021 Results August 10, 2021
Published: 2021-08-02 (Crawled : 21:00) - globenewswire.com
CLPT | $5.35 -0.74% -0.75% 130K

Health Technology

| -73.94% | O: -0.05% H: 0.0% C: -5.47%
results

AGTC to Participate at Upcoming Investor Conferences
Published: 2021-08-02 (Crawled : 21:00) - globenewswire.com
OTIC | $0.077

Health Technology